PPARGC1a gene polymorphisms and lower expression of PPARGC1a are important contributors of NAFLD [37] and also in our samples we found lower expression in the ASH than in the control. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.